Pembrolizumab plus chemotherapy for advanced gastric cancer – Authors' reply

Sun Young Rha, Sonal Bordia

Research output: Contribution to journal › Letter › peer-review

Access to Document

@article{eba5dfe6d92c4ddb8ade670c8c37d796,

title = "Pembrolizumab plus chemotherapy for advanced gastric cancer – Authors' reply",

author = "Rha, \{Sun Young\} and Sonal Bordia",

year = "2024",

month = feb,

doi = "10.1016/S1470-2045(24)00022-6",

language = "English",

volume = "25",

pages = "e52",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "2",

}

TY - JOUR

T1 - Pembrolizumab plus chemotherapy for advanced gastric cancer – Authors' reply

AU - Rha, Sun Young

AU - Bordia, Sonal

PY - 2024/2

Y1 - 2024/2

UR - https://www.scopus.com/pages/publications/85183651878

U2 - 10.1016/S1470-2045(24)00022-6

DO - 10.1016/S1470-2045(24)00022-6

M3 - Letter

AN - SCOPUS:85183651878

SN - 1470-2045

VL - 25

SP - e52

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 2

ER -